India is assessing broad health insurance reforms, including benchmarked treatment rates and a national claims exchange, as policymakers seek more pricing transparency and a way to slow some of Asia’s highest medical inflation, two people familiar with the talks said.
Medical inflation runs at roughly 12% to 14% a year, according to industry estimates. That rate strains household budgets and pushes regulators to look for standard pricing and clearer coverage rules, the people said.
A panel of regulators, insurers, hospitals and the Confederation of Indian Industry is expected to submit reform recommendations by year-end. Implementation would follow later, said the people, who asked not to be named because the discussions remain private, Reuters noted.
Industry estimates put unwarranted or fraudulent health claims at 10% to 15%, one of the people said.
The chair of the Insurance Regulatory and Development Authority of India leads the panel, the people said. IRDAI did not respond to requests for comment.
India wants more of its 1.4 bn population to buy insurance. Insurance spending stands below 4% of GDP, compared with a global average above 7%.
The government has raised foreign investment limits and changed distribution rules across its $130 bn insurance market as part of that push.
More than 40 insurers operate in India’s health insurance market, including joint ventures linked to global groups such as Lombard, ERGO and AIG. The market generated about 1.17 trillion rupees ($12.3 bn) in premiums during the fiscal year ended March 2025.
Lawmakers urged government action to make private healthcare more affordable, as consumer costs keep rising and officials put health insurance under closer review.
Private hospital stays in India cost about $530 on average, compared with about $70 at public facilities, a parliamentary committee report showed last week.
According to Beinsure analysts, standard tariffs and clearer billing rules give regulators the most direct tools to slow medical-cost growth over time. One of the people familiar with the discussions made the same point, describing pricing transparency as the largest lever under review.
The proposed reforms include a common health insurance product that every insurer would have to offer alongside existing plans. The product would seek to standardise coverage and rates for a defined set of illnesses and procedures, the people said.
A national claims exchange would also give insurers, hospitals and regulators a shared structure for processing health claims. The intended result is less friction over treatment rates, fewer disputed bills and better detection of suspicious claims. Sounds bureaucratic, yes, but the claims data problem is real.
For insurers, the plan would mean tighter control over hospital billing and a more uniform baseline product. For hospitals, it would mean more scrutiny over tariffs and documentation. For consumers, the policy goal is simpler comparison across insurers, though pricing pressure will depend on how the benchmarks get set and enforced.
